GeneReach Biotechnology Statistics
Total Valuation
TPEX:4171 has a market cap or net worth of TWD 693.67 million. The enterprise value is 524.84 million.
Important Dates
The next estimated earnings date is Friday, March 26, 2027.
| Earnings Date | Mar 26, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:4171 has 56.86 million shares outstanding. The number of shares has decreased by -1.02% in one year.
| Current Share Class | 56.86M |
| Shares Outstanding | 56.86M |
| Shares Change (YoY) | -1.02% |
| Shares Change (QoQ) | -1.09% |
| Owned by Insiders (%) | 17.29% |
| Owned by Institutions (%) | n/a |
| Float | 38.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.88 |
| PB Ratio | 1.24 |
| P/TBV Ratio | 1.27 |
| P/FCF Ratio | 109.45 |
| P/OCF Ratio | 36.53 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 56.04, with an EV/FCF ratio of 82.81.
| EV / Earnings | n/a |
| EV / Sales | 2.18 |
| EV / EBITDA | 56.04 |
| EV / EBIT | n/a |
| EV / FCF | 82.81 |
Financial Position
The company has a current ratio of 2.50, with a Debt / Equity ratio of 0.35.
| Current Ratio | 2.50 |
| Quick Ratio | 2.21 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 21.44 |
| Debt / FCF | 31.68 |
| Interest Coverage | -9.46 |
Financial Efficiency
Return on equity (ROE) is -4.31% and return on invested capital (ROIC) is -10.03%.
| Return on Equity (ROE) | -4.31% |
| Return on Assets (ROA) | -2.60% |
| Return on Invested Capital (ROIC) | -10.03% |
| Return on Capital Employed (ROCE) | -6.97% |
| Weighted Average Cost of Capital (WACC) | 5.42% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.28 |
| Inventory Turnover | 1.57 |
Taxes
| Income Tax | -3.97M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.46% in the last 52 weeks. The beta is 0.40, so TPEX:4171's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -36.46% |
| 50-Day Moving Average | 16.33 |
| 200-Day Moving Average | 17.97 |
| Relative Strength Index (RSI) | 16.70 |
| Average Volume (20 Days) | 96,231 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4171 had revenue of TWD 241.13 million and -22.11 million in losses. Loss per share was -0.39.
| Revenue | 241.13M |
| Gross Profit | 178.37M |
| Operating Income | -44.74M |
| Pretax Income | -28.92M |
| Net Income | -22.11M |
| EBITDA | -2.45M |
| EBIT | -44.74M |
| Loss Per Share | -0.39 |
Full Income Statement Balance Sheet
The company has 377.77 million in cash and 200.78 million in debt, with a net cash position of 176.99 million or 3.11 per share.
| Cash & Cash Equivalents | 377.77M |
| Total Debt | 200.78M |
| Net Cash | 176.99M |
| Net Cash Per Share | 3.11 |
| Equity (Book Value) | 566.74M |
| Book Value Per Share | 10.00 |
| Working Capital | 273.59M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 18.99 million and capital expenditures -12.65 million, giving a free cash flow of 6.34 million.
| Operating Cash Flow | 18.99M |
| Capital Expenditures | -12.65M |
| Depreciation & Amortization | 42.29M |
| Net Borrowing | -21.49M |
| Free Cash Flow | 6.34M |
| FCF Per Share | 0.11 |
Full Cash Flow Statement Margins
Gross margin is 73.97%, with operating and profit margins of -18.55% and -9.17%.
| Gross Margin | 73.97% |
| Operating Margin | -18.55% |
| Pretax Margin | -11.99% |
| Profit Margin | -9.17% |
| EBITDA Margin | -1.02% |
| EBIT Margin | -18.55% |
| FCF Margin | 2.63% |
Dividends & Yields
TPEX:4171 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.02% |
| Shareholder Yield | 1.02% |
| Earnings Yield | -3.20% |
| FCF Yield | 0.91% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on July 28, 2023. It was a forward split with a ratio of 1.25.
| Last Split Date | Jul 28, 2023 |
| Split Type | Forward |
| Split Ratio | 1.25 |
Scores
TPEX:4171 has an Altman Z-Score of 2.77 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.77 |
| Piotroski F-Score | 5 |